News Shortcuts from other journals

New drug for atrial fibrillation passes its first test

BMJ 2007; 335 doi: (Published 13 September 2007) Cite this as: BMJ 2007;335:537

Sanofi Aventis has developed a new drug treatment for atrial fibrillation. Dronedarone is a modified relative of amiodarone, and it worked well in two identical placebo controlled trials. Participants were in sinus rhythm when randomised, and the drug kept them in sinus …

View Full Text

Log in

Log in through your institution


* For online subscription